Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. Post author:Sam Post published:December 18, 2017 Post category:BioPharma The FDA broke new ground today with a first-of-its-kind therapy for eye disease. Source: BioSpace You Might Also Like Get Ready for the M&A Explosion January 30, 2018 3 Rock-Bottom Biotechs That Big Market Players are Betting On May 15, 2017 13-Employee SoCal Startup Bioniz Has A $400 Million Valuation December 19, 2017
